Back
Speaker illustration

Professor Vidal Essebag

McGill University Health Centre, Montreal (Canada)

Member of:

European Society of Cardiology
European Heart Rythm Association

Dr. Vidal Essebag completed his MD, cardiology training, MSc and PhD in epidemiology and biostatistics at McGill University (Montreal, Canada). He subsequently completed a clinical and research fellowship in cardiac electrophysiology at Harvard University (Boston, United States) under Dr. Mark E. Josephson. He is Director of Cardiac Electrophysiology at the McGill University Health Centre, Professor of Medicine at McGill University, and a Clinician Scientist supported by the Canadian Institutes of Health Research (CIHR) and the Fonds de recherche du Québec - Santé (FRQS). Dr. Essebag currently has over 190 publications in peer-reviewed journals and is a principal investigator or co-investigator in several clinical trials including ablation of atrial fibrillation and ventricular tachycardia, defibrillator and cardiac resynchronization therapy and peri-operative anticoagulation management. He has also been actively involved in national guideline committees including atrial fibrillation,

Presentations Articles

Acute procedural characteristics and safety of pulsed field cryoablation for persistent AF: multicenter results from the first in human PARALELL trial

Event: EHRA 2024

Topic: Catheter Ablation of Arrhythmias

Session: Arrhythmias 4

Access
Thumbnail

Mitral isthmus-dependent flutter ablation: anterior or posterior line?

Event: EHRA 2023

Topic: Clinical

Session: All about...atrial tachycardias

Access
Thumbnail

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: a secondary analysis of the BRUISE CONTROL trial

Event: EHRA 2019

Topic: Device Complications and Lead Extraction

Session: Moderated ePosters 15: Implantable device therapy : the good, the bad and the ugly

Access
Thumbnail

Cardiac resynchronization therapy programming to improve electrical synchrony: adjusting the atrioventricular conduction delay

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Access
Thumbnail

Randomized controlled trials of continued versus interrupted oral anti-coagulant at the time of device surgery: Combined analysis of BRUISE CONTROL 1 and 2

Event: EHRA 2018

Topic: Device Complications and Lead Extraction

Session: Late-Breaking Trials

Access
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources